Standing Order
Perspective Therapeutics, Inc.

Dashboard

Perspective Therapeutics, Inc.

CATXNYSE American

For informational purposes only. Not financial advice, not a recommendation to buy or sell any security. Standing Order is a directory and research project, not an advisory service.

Universal block

Live market data + trailing fundamentals.

Market cap$332M
Price$2.9152w $2.05 – $5.65
Conviction3/ 5
Revenue (TTM)$618,000
Revenue growth YoY-58.0%
P/E (trailing)
Gross margin-489.8%
Operating margin-19419.6%
Net margin-17982.7%
52w price change+21.8%
Next earningsAug 12, 2026

Recent events

Material filings, federal awards, and regulatory activity. Impact is scored against market cap.

  • Jul 1
    OtherSEC

    8-K filing with items 8.01 (other events) and 9.01.

  • Jun 1
    OtherSEC

    8-K filing (items 8.01, 9.01) on 2026-06-01 disclosing other events.

  • May 27
    OtherSEC

    8-K item 5.07 filing on matters submitted to security holder vote.

  • May 22
    OtherSEC

    Filed 8-K on 2026-05-22 covering items 8.01 (other events) and 9.01.

  • May 11
    Financial resultsSEC

    8-K filing (items 2.02, 8.01, 9.01) reporting financial results.

Not financial advice — research and opinion only. Disclosures